Dick Howitt
CEO & President
Replay available
Cochlear Plc Ord (OTC: CHEOF) Q2 2025 earnings conference call, held 2025-02-13. Replay captured from the company's public earnings webcast.

CEO & President
President Asia Pacific & Latin America, former CFO
Analyst, MST Marquee
Analyst, J.P. Morgan
Analyst, Baron Joey
Analyst, Jefferies
Analyst, Jarden
Analyst, Citi
Analyst, RBC
Analyst, Evans and Partners
Analyst, UBS
by and welcome to the Cochlear Limited Half Year 25 Result Analyst and Media Briefing. All participants are in a listen only mode. There will be a presentation followed by a question and answer session. If you would like to ask a question you'll need to press the star key followed by the number 1 on your telephone keypad. I'd now like to hand the conference over to Mr. Dick Howitt, CEO and President. Please go ahead. Good morning everyone and thanks for joining for our Half Year Results presentation. So here with me today have Stu Sayers and Sarah Tom. And Stu, who was our CFO until the end of December and is now President of Asia Pacific and Latin America, will talk about the result because it's the result for the last half. Sarah, as our new CFO, is here with me as well. Okay, so thanks for joining. Let's get underway. And we have our mission up front because... That does guide all that we do at Cochlear and it also sets out our longer run ambition and underpins our long-term strategy for growth. So looking back at the first half of this year, overall we were pretty happy with the outcome but clearly as you look into it, there's some mixed results in there. So strong cochlear implant revenue growth at 13%, acoustics revenue very strong at 22%, and services, which we'll obviously talk more about, declining by 12%, but all of that giving us a net sales increase of 6% in constant currency. Our underlying net profit moved pretty much in line with sales on a reported basis, with our profit up 7% to $206 million. Gross margin that Stu will talk more about in line with our targets and our operating expenses up 10%, so a bit faster than sales and that's not unusual for us early in the year as we continue to invest into R&D and very much into driving growth. Balance sheet r...